NCT01487811View on ClinicalTrials.gov

Comparison of Two Biphasic Insulin Aspart 30 Formulations (Current and New Formulation) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

DiabetesHealthy

Interventions

DRUG

biphasic insulin aspart 30

Single dose administrated subcutaneously (s.c., under the skin)

Trial Locations (1)

78229

Novo Nordisk Investigational Site, San Antonio

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY